M. Derksen

Dolutegravir as maintenance monotherapy for HIV (DOMONO): a phase 2, randomised non-inferiority trial.

Eleni-Rosalina Andrinopoulou, Bart Rijnders, E. Andrinopoulou, 2017, The lancet. HIV.

International Congress of Drug Therapy in HIV Infection 23-26 October 2016, Glasgow, UK

Raúl Tabarés Gutiérrez, Samit R. Joshi, H. Jessen, 2016, Journal of the International AIDS Society.

Chapter 2 Dolutegravir as maintenance monotherapy for HIV ( DOMONO ) : a phase 2 , randomised non-inferiority trial

C. Boucher, W. Bierman, H. Bax, 2018 .